Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Department of Pharmacology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
Neuropharmacology. 2018 Jan;128:474-481. doi: 10.1016/j.neuropharm.2017.08.005. Epub 2017 Aug 9.
The purinergic system consists of two large receptor families - P2X and P2Y. Both are activated by adenosine triphosphate (ATP), although presenting different functions. These receptors are present in several brain regions, including those involved in emotion and stress-related behaviors. Hence, they seem to participate in fear- and anxiety-related responses. However, few studies have investigated the purinergic system in threatening situations, as observed in contextual fear conditioning (CFC). Therefore, this study investigated the involvement of purinergic receptors in the expression and extinction of aversive memories. C57Bl/6 background mice were submitted to the CFC protocol. Wildtype (WT) mice received i.p. injection of either a nonselective P2 receptor (P2R) antagonist, P178 (10 or 30 mg/kg); a selective P2X7 receptor (P2X7R) antagonist, A438079 (10 mg/kg); a selective P2Y1 receptor (P2Y1R) antagonist, MRS2179 (10 mg/kg); or vehicle 10 min prior to or immediately after the extinction session. Additionally, P2X7R KO mice were tested in the CFC protocol. After P2R antagonist treatment, contextual fear recall increased, while acquisition of extinction was impaired. Similar results were observed with the selective P2X7R antagonist, but not with the selective P2Y1R antagonist. Interestingly, P2X7R KO mice showed increased contextual fear recall, associated with impaired acquisition of extinction, in accordance with pharmacologic P2X7R antagonism. Our results suggest that specific pharmacological or genetic blockade of P2X7R promotes anxiogenic-like effects, along with deficits in extinction learning. Thus, these receptors could present an alternative treatment of stress-related psychiatric disorders.
嘌呤能系统由两个大型受体家族组成 - P2X 和 P2Y。两者均被三磷酸腺苷 (ATP) 激活,尽管具有不同的功能。这些受体存在于多个脑区,包括涉及情绪和应激相关行为的脑区。因此,它们似乎参与了与恐惧和焦虑相关的反应。然而,很少有研究调查嘌呤能系统在威胁情况下的作用,如在情境恐惧条件反射 (CFC) 中观察到的那样。因此,本研究调查了嘌呤能受体在厌恶记忆的表达和消退中的作用。C57Bl/6 背景小鼠接受 CFC 方案。野生型 (WT) 小鼠接受腹腔注射非选择性 P2 受体 (P2R) 拮抗剂 P178(10 或 30mg/kg);选择性 P2X7 受体 (P2X7R) 拮抗剂 A438079(10mg/kg);选择性 P2Y1 受体 (P2Y1R) 拮抗剂 MRS2179(10mg/kg);或在消退期之前或之后 10 分钟内给予载体。此外,P2X7R KO 小鼠在 CFC 方案中进行了测试。在 P2R 拮抗剂治疗后,情境恐惧回忆增加,而消退的获得受损。选择性 P2X7R 拮抗剂也观察到类似的结果,但选择性 P2Y1R 拮抗剂则没有。有趣的是,P2X7R KO 小鼠表现出增加的情境恐惧回忆,伴随着消退的获得受损,与药理学上的 P2X7R 拮抗作用一致。我们的结果表明,特定的药理学或遗传学阻断 P2X7R 可促进焦虑样效应,同时消退学习受损。因此,这些受体可能为应激相关精神障碍提供一种替代治疗方法。